SCI Pharmtech Inc (4119) — Long-term Investment Intensity
SCI Pharmtech Inc (4119) has a Long-term Investment Intensity of 3.4% as of December 2019. Long-term investments of NT$137.33 Million represent 3.4% of total assets of NT$4.08 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See SCI Pharmtech Inc net assets for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
SCI Pharmtech Inc Long-term Investment Intensity (2013–2019)
This chart shows how SCI Pharmtech Inc's Long-term Investment Intensity has evolved across 7 annual periods from 2013 to 2019. As of December 2019, the intensity stands at 3.4%, reflecting long-term investments of NT$137.33 Million against total assets of NT$4.08 Billion TWD. Also explore balance sheet size of SCI Pharmtech Inc for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for SCI Pharmtech Inc (2013–2019)
The table below presents the year-by-year Long-term Investment Intensity for SCI Pharmtech Inc from 2013 to 2019, covering 7 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see SCI Pharmtech Inc market cap and net worth.
| Year | LT Investment Intensity | LT Investments (TWD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 3.4% | NT$137.33 Million | NT$4.08 Billion | ▲ +1.4 pp |
| 2018 | 2.0% | NT$75.30 Million | NT$3.79 Billion | ▲ +0.7 pp |
| 2017 | 1.3% | NT$42.37 Million | NT$3.30 Billion | ▲ +0.1 pp |
| 2016 | 1.2% | NT$42.37 Million | NT$3.55 Billion | ▼ 0.0 pp |
| 2015 | 1.2% | NT$42.37 Million | NT$3.46 Billion | ▼ -0.3 pp |
| 2014 | 1.6% | NT$50.09 Million | NT$3.22 Billion | ▲ +0.6 pp |
| 2013 | 1.0% | NT$29.87 Million | NT$3.05 Billion | — |